Preeclampsia (PE) affects 5‐8% of pregnant women, and it is the major cause of perinatal
morbidity and mortality. It is defined as arterial hypertension in women after 20 weeks of …

Preeclampsia, defined as new-onset hypertension accompanied by proteinuria occurring at
20 weeks of gestation or later, is a leading cause of perinatal morbidity and mortality …

Systemic manifestation of preeclampsia (PE) is associated with circulating factors, including
inflammatory cytokines and damage-associated molecular patterns (DAMPs), or alarmins …

Inflammasomes are cytoplasmic multiprotein complexes that coordinate inflammatory
responses, including those that take place during pregnancy. Inflammasomes and their …

Preeclampsia (PE) is a human pregnancy-specific syndrome with abnormal activation of
cells from the innate immune system. The present study evaluated whether silibinin (SB) …

Pregnancy-induced hypertension and preeclampsia are associated with significant maternal
and fetal mortality. A better understanding of these diseases, delineation of molecular …

Preeclampsia is a serious complication of pregnancy and leads to maternal hypertension
and proteinuria. It remains a major health problem for mothers and babies across the world …

The endothelium, which constitutes the inner layer of blood vessels and lymphatic
structures, plays an important role in various physiological functions. Alterations in structure …

The balance of the inflammatory response is indispensable during pregnancy.
Inflammasomes are the cytosolic supramolecular protein complexes activated by pattern …

This study evaluated the in vitro modulatory effect of progesterone (PG) and vitamin D (VD)
on NLRP1/NLRP3 inflammasomes and TLR4/NF-κB pathway in monocytes from pregnant …